中国卫生标准管理
中國衛生標準管理
중국위생표준관리
China Health Standard Management
2015年
28期
195-196
,共2页
超声%抗甲状腺药物%原发性甲状腺功能亢进症
超聲%抗甲狀腺藥物%原髮性甲狀腺功能亢進癥
초성%항갑상선약물%원발성갑상선공능항진증
Ultrasound%Anti thyroid drugs%Primary hyperthyroidism
目的：通过超声观察抗甲状腺药物治疗原发性甲状腺功能亢进症的临床效果。方法将72例经抗甲状腺药物治疗患者，按照超声诊断分为A（均匀回声型）和B（不均匀回声型）组各36例。结果 A组总有效率91.7%高于B组47.2%，P＜0.01；两组治疗后甲状腺体积缩小，血流及流速降低，阻力提高，P＜0.05；A组甲状腺体积小于B组，P＜0.05，与C组对比，P＞0.05。结论在治疗原发性甲状腺功能亢进症时，通过超声判断患者分型，采取针对性方法治疗，而均匀回声型患者宜采取抗甲状腺药物治疗，优于不均匀回声型患者。
目的：通過超聲觀察抗甲狀腺藥物治療原髮性甲狀腺功能亢進癥的臨床效果。方法將72例經抗甲狀腺藥物治療患者，按照超聲診斷分為A（均勻迴聲型）和B（不均勻迴聲型）組各36例。結果 A組總有效率91.7%高于B組47.2%，P＜0.01；兩組治療後甲狀腺體積縮小，血流及流速降低，阻力提高，P＜0.05；A組甲狀腺體積小于B組，P＜0.05，與C組對比，P＞0.05。結論在治療原髮性甲狀腺功能亢進癥時，通過超聲判斷患者分型，採取針對性方法治療，而均勻迴聲型患者宜採取抗甲狀腺藥物治療，優于不均勻迴聲型患者。
목적：통과초성관찰항갑상선약물치료원발성갑상선공능항진증적림상효과。방법장72례경항갑상선약물치료환자，안조초성진단분위A（균균회성형）화B（불균균회성형）조각36례。결과 A조총유효솔91.7%고우B조47.2%，P＜0.01；량조치료후갑상선체적축소，혈류급류속강저，조력제고，P＜0.05；A조갑상선체적소우B조，P＜0.05，여C조대비，P＞0.05。결론재치료원발성갑상선공능항진증시，통과초성판단환자분형，채취침대성방법치료，이균균회성형환자의채취항갑상선약물치료，우우불균균회성형환자。
Objective By ultrasound to observe anti-thyroid drugs the clinical effect of primary hyperthyroidism.Methods72 patients after anti-thyroid drugs, according to the ultrasonic diagnosis is divided into A uniform(echo)and B(uneven echo type)group of 36 cases.Results91.7% of the total effective rate was 91.7% higher than that of group B,group A(P<0.01),two groups after treatment of thyroid volume shrinking,blood flow and flow velocity is reduced,the resistance increase,P<0.05,group A thyroid volume less than group B,P<0.05,compared with group C,P>0.05. Conclusion In the treatment of primary hyperthyroidism,the patients were treated by the method of the ultrasound. The patients with uniform echo type were treated with anti thyroid drugs,which is superior to those of patients with non uniform echo.
